Table of Contents: Volume 15, Issue 1 - January 2007
Satraplatin in the Treatment of Hormone Refractory Prostate Cancer
Oliver Sartor, Dana-Farber Cancer Institute, Boston
[04:04 min:sec]
Chemotherapy and Immunotherapy Working Together in Hormone Refractory Prostate Cancer
Daniel Petrylak, Columbia Presbyterian Medical Center, New York
[03:22 min:sec]
Resectable Pancreatic Cancer: Adjuvant Chemotherapy Improves Outlook
John Neoptolemos, Royal Liverpool University Hospital
[06:00 min:sec]
Gastric Cancer: Better Survival With Perioperative Chemotherapy
David Cunningham, Royal Marsden Hospital, London
[04:48 min:sec]
Lapatinib Benefits Patients With HER2+ Refractory Breast Cancer Pretreated With Chemotherapy and Trastuzumab
David Cameron, Western General Hospital, Edinburgh
[08:18 min:sec]
EVEREST Study: Some Patients With Metastatic Colorectal Cancer Can Benefit From Higher Cetuximab Doses
Eric Van Cutsem, University Hospital Gasthuisberg, Leuven, Belgium
[04:15 min:sec]
Capecitabine Good For Metastatic Colorectal Cancer; Bevacizumab Brings Further Benefit
Jim Cassidy, University of Glasgow
[03:42 min:sec]
No Colorectal Cure From Complete Removal of Liver Metastases
George Canellos, Dana-Farber Cancer Institute
[03:47 min:sec]
Targeting HER2 After Progression on Trastuzumab is Viable
Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York
[04:37 min:sec]
Therapeutic Vaccine for Cervical Neoplasia
Mark Einstein, Albert Einstein College of Medicine, New York
[03:40 min:sec]
Cloretazine: An Alkylating Agent as Second Line in the Treatment of Small Cell Lung Cancer
Frank Anthony Greco, Sarah Cannon Cancer Center, Nashville
[05:34 min:sec]
Multiple Myeloma: Promise for Arsenic Trioxide
James R. Berenson, Institute for Myeloma and Bone Cancer Research, Hollywood, California
[05:15 min:sec]
Listen to this audio by subscribing to the Podcast |
|---|